Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety

World Journal of Gastroenterology

Volumn 20, Issue 32, 2014, Pages 11422-11428

  Lan, Ling ^a   Chen, Yu Long ^b   Zhang, Hao ^a   Jia, Bai Ling ^a   Chu, Yan Jun ^b   Wang, Jin ^b   Tang, Shi Xiao ^c   Xia, Guo Dong ^c  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Anxiety; Efficacy; Irritable bowel syndrome; Safety; Tandospirone

Indexed keywords

PINAVERIUM; PLACEBO; TANDOSPIRONE; ANXIOLYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; ISOINDOLE DERIVATIVE; MORPHOLINE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ABDOMINAL PAIN; ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT DURATION; TREATMENT OUTCOME; VERTIGO; VOMITING; YOUNG ADULT; CHINA; CLINICAL TRIAL; COMPLICATION; DRUG ADMINISTRATION; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; MULTICENTER STUDY; PAIN MEASUREMENT; PSYCHOLOGY; QUESTIONNAIRE; SINGLE BLIND PROCEDURE; TIME;

ABDOMINAL PAIN; ADULT; AGED; ANTI-ANXIETY AGENTS; ANXIETY; CALCIUM CHANNEL BLOCKERS; CHINA; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; ISOINDOLES; MALE; MIDDLE AGED; MORPHOLINES; PAIN MEASUREMENT; PIPERAZINES; PROSPECTIVE STUDIES; PYRIMIDINES; QUESTIONNAIRES; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84909609664     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i32.11422     Document Type: Article

References (36)

1. Chang FY. Irritable bowel syndrome: the evolution of multidimensional looking and multidisciplinary treatments. World J Gastroenterol 2014; 20: 2499-2514 [PMID: 24627587 DOI: 10.3748/wjg.v20.i10.2499]
2. Thijssen AY, Jonkers DM, Leue C, van der Veek PP, Vida-kovic-Vukic M, van Rood YR, Clemens CH, Masclee AA. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J Clin Gastroenterol 2010; 44: e236-e241 [PMID: 20733511 DOI: 10.1097/MCG.0b013e3181eed5d8]
3. Kabra N, Nadkarni A. Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India. Indian J Psychiatry 2013; 55: 77-80 [PMID: 23439939 DOI: 10.4103/0019-5545.105520]
4. Dragoş D, Ionescu O, Ojog DG, Tənəsescu MD. Psychoemotional features in irritable bowel syndrome. J Med Life 2012; 5: 398-409 [PMID: 23346240]
5. Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs 2013; 22: 329-339 [PMID: 23316916 DOI: 10.1517/13543784.2013.761205]
6. Grover M, Camilleri M. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. J Gastroenterol 2013; 48: 177-181 [PMID: 23254779 DOI: 10.1007/s00535-012-0726-5]
7. Pae CU, Lee SJ, Han C, Patkar AA, Masand PS. Atypical antipsychotics as a possible treatment option for irritable bowel syndrome. Expert Opin Investig Drugs 2013; 22: 565-572 [PMID: 23506326 DOI: 10.1517/13543784.2013.782392]
8. Yao X, Yang YS, Cui LH, Zhao KB, Zhang ZH, Peng LH, Guo X, Sun G, Shang J, Wang WF, Feng J, Huang Q. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study. J Gastroenterol Hepatol 2012; 27: 760-765 [PMID: 21929652 DOI: 10.1111/j.1440-1746.2011.06930.x]
9. Lee S, Wu J, Ma YL, Tsang A, Guo WJ, Sung J. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther 2009; 30: 643-651 [PMID: 19552631 DOI: 10.1111/j.1365-2036.2009.04074.x]
10. Tao M, Han YJ, Gao JF, Tang WX, Zhu XZ, Tao DH, Zhang P, Zou Y, Chen H, Tao SF. [Efficacy and safety of tandospirone in the treatment of patients with anxiety disorder]. Zhonghua Yi Xue Zazhi 2012; 92: 920-923 [PMID: 22781535]
11. Nishitsuji K, To H, Murakami Y, Kodama K, Kobayashi D, Yamada T, Kubo C, Mine K. Tandospirone in the treatment of generalised anxiety disorder and mixed anxietydepression: results of a comparatively high dosage trial. Clin Drug Investig 2004; 24: 121-126 [PMID: 17516698 DOI: 10.2165/00044011-200424020-00007]
12. Rome Foundation. Guidelines - Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. J Gastrointestin Liver Dis 2006; 15: 307-312 [PMID: 17203570]
13. The American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, Text revision. Washington, DC: American Psychiatric Association; 2000
14. Matza LS, Morlock R, Sexton C, Malley K, Feltner D. Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. Int J Methods Psychiatr Res 2010; 19: 223-232 [PMID: 20718076 DOI: 10.1002/mpr.323]
15. Naliboff BD, Kim SE, Bolus R, Bernstein CN, Mayer EA, Chang L. Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis. Am J Gastroenterol 2012; 107: 451-459 [PMID: 22085819 DOI: 10.1038/ajg.2011.377]
16. Maguen S, Madden E, Cohen B, Bertenthal D, Seal K. Association of mental health problems with gastrointestinal disorders in Iraq and Afghanistan veterans. Depress Anxiety 2014; 31: 160-165 [PMID: 23494973 DOI: 10.1002/da.22072]
17. Kanazawa M, Endo Y, Whitehead WE, Kano M, Hongo M, Fukudo S. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci 2004; 49: 1046-1053 [PMID: 15309899 DOI: 10.1023/B: DDAS.0000034570.52305.10]
18. Surdea-Blaga T, Bəban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol 2012; 18: 616-626 [PMID: 22363132 DOI: 10.3748/wjg.v18.i7.616]
19. Jarrett ME, Burr RL, Cain KC, Hertig V, Weisman P, Heitkemper MM. Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci 2003; 48: 386-394 [PMID: 12643620 DOI: 10.1023/A:1021904216312]
20. Jerndal P, Ringström G, Agerforz P, Karpefors M, Akkermans LM, Bayati A, Simrén M. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterol Motil 2010; 22: 646-e179 [PMID: 20367800 DOI: 10.1111/j.1365-2982.2010.01493.x]
21. Mayer EA, Naliboff BD, Chang L, Coutinho SV. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001; 280: G519-G524 [PMID: 11254476]
22. Labus J, Gupta A, Gill HK, Posserud I, Mayer M, Raeen H, Bolus R, Simren M, Naliboff BD, Mayer EA. Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment Pharmacol Ther 2013; 37: 304-315 [PMID: 23205588 DOI: 10.1111/apt.12171]
23. Kearney DJ, McDermott K, Martinez M, Simpson TL. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life. Aliment Pharmacol Ther 2011; 34: 363-373 [PMID: 21651595 DOI: 10.1111/j.1365-2036.2011.04731.x]
24. Gros DF, Antony MM, McCabe RE, Lydiard RB. A preliminary investigation of the effects of cognitive behavioral therapy for panic disorder on gastrointestinal distress in patients with comorbid panic disorder and irritable bowel syndrome. Depress Anxiety 2011; 28: 1027-1033 [PMID: 21770001 DOI: 10.1002/da.20863]
25. Enck P, Junne F, Klosterhalfen S, Zipfel S, Martens U. Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2010; 22: 1402-1411 [PMID: 21389791]
26. Kawana S, Kato Y, Omi T. Efficacy of a 5-HT1a receptor agonist in atopic dermatitis. Clin Exp Dermatol 2010; 35: 835-840 [PMID: 20089082 DOI: 10.1111/j.1365-2230.2009.03771.x]
27. Shimizu H, Karai N, Hirose A, Tatsuno T, Tanaka H, Kumasaka Y, Nakamura M. Interaction of SM-3997 with serotonin receptors in rat brain. Jpn J Pharmacol 1988; 46: 311-314 [PMID: 2898033 DOI: 10.1254/jjp.46.311]
28. Miwa H, Nagahara A, Tominaga K, Yokoyama T, Sawada Y, Inoue K, Ashida K, Fukuchi T, Hojo M, Yamashita H, Tomita T, Hori K, Oshima T. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol 2009; 104: 2779-2787 [PMID: 19638966 DOI: 10.1038/ajg.2009.427]
29. Kindt S, Tack J. Impaired gastric accommodation and its role in dyspepsia. Gut 2006; 55: 1685-1691 [PMID: 16854999 DOI: 10.1136/gut.2005.085365]
30. Yamada K. Clinical application of 5-HT1A agonist tandospirone in mind and physique domain. Med Adv 2007; 223: 653-657
31. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007; 132: 397-414 [PMID: 17241888 DOI: 10.1053/j.gastro.2006.11.002]
32. Kinoshita Y, Hashimoto T, Kawamura A, Yuki M, Amano K, Sato H, Adachi K, Sato S, Oshima N, Takashima T, Kitajima N, Abe K, Suetsugu H. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. Aliment Pharmacol Ther 2005; 21 Suppl 2: 37-41 [PMID: 15943845 DOI: 10.1111/j.1365-2036.2005.02472.x]
33. Seno H, Nakase H, Chiba T. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies. Aliment Pharmacol Ther 2005; 21 Suppl 2: 32-36 [PMID: 15943844 DOI: 10.1111/j.1365-2036.2005.02471.x]
34. Fukudo S, Kanazawa M. Gene, environment, and braingut interactions in irritable bowel syndrome. J Gastroenterol Hepatol 2011; 26 Suppl 3: 110-115 [PMID: 21443722 DOI: 10.1111/j.1440-1746.2011.06631.x]
35. Boyer WF. Potential indications for the selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 1992; 6 Suppl 5: 5-12 [PMID: 1431022 DOI: 10.1097/00004850-199206005-00001]
36. Evans J, Sun Y, McGregor A, Connor B. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology 2012; 63: 1315-1326 [PMID: 22939998 DOI: 10.1016/j.neuropharm.2012.08.012]